NASDAQ:APLS

Apellis Pharmaceuticals Stock Forecast

etoro logo Buy APLS
*Your capital is at risk
$41.03
+0 (+0%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of APLS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add APLS to Watchlist?
Some Reasons Why To Add APLS:
  • +117.9% price growth over the last year
  • High gross margin of 90.1%
  • Lower volatility than the market (beta -0.25)
PDF

Apellis Pharmaceuticals Inc. stock price down 0% on Friday
(Updated on Jun 12, 2026)

Buy or Hold candidate since Apr 06, 2026 Gain 0.98%

No changes to the price of Apellis Pharmaceuticals Inc. stock on the last trading day (Friday, 12th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $41.03 to a day high of $41.03. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 56.65% during the next 3 months and, with a 90% probability hold a price between $54.29 and $91.07 at the end of this 3-month period.

APLS Signals & Forecast

The Apellis Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $41.03 and $41.02. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -0.219%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, March 24, 2026 with a target of $17.89. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Apellis Pharmaceuticals Inc. stock

Apellis Pharmaceuticals Inc. finds support from accumulated volume at $40.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $39.38 (-4.03%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 26 days ago.)

Trading Expectations (APLS) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Apellis Pharmaceuticals Inc. to open at $41.03, and during the day (based on 14 day Average True Range), to move between $40.99 and $41.07, which gives a possible trading interval of +/-$0.0733 (+/-0.18%) up or down from last closing price. If Apellis Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 0.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $41.06 (0.07%) than the support at $40.94 (0.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Apellis Pharmaceuticals Inc. stock A Buy?

Apellis Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $41.03 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

APLS Performance

Trading levels for APLS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 41.03 -
R2 41.03 -
R1 41.03 -
Price 41.03
S1 41.03 -
S2 41.03 -
S3 41.03 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 41.12 0.219%
R1 41.06 0.0731%
Price 41.03
S1 40.94 -0.219%
S2 40.39 -1.56%
S3 40.23 -1.95%

FAQ

What is the symbol for Apellis Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Apellis Pharmaceuticals Inc. is APLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Apellis Pharmaceuticals Inc. Stock?
Apellis Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Apellis Pharmaceuticals Inc. Stock?
Apellis Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Apellis Pharmaceuticals Inc. Stock.

What's the current price of Apellis Pharmaceuticals Inc. Stock?
As of the end of day on the Jun 12, 2026, the price of an Apellis Pharmaceuticals Inc. (APLS) share was $41.03.

What is the 52-week high and low for Apellis Pharmaceuticals Inc. Stock?
The 52-week high for Apellis Pharmaceuticals Inc. Stock is $41.12 and the 52-week low is $16.83.

What is the market capitalization of Apellis Pharmaceuticals Inc. Stock?
As of the Jun 12, 2026, the market capitalization of Apellis Pharmaceuticals Inc. is 5.253B.

When is the next earnings date for Apellis Pharmaceuticals Inc.?
The upcoming earnings date for Apellis Pharmaceuticals Inc. is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT APELLIS PHARMACEUTICALS INC.
Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal ...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE